Accenture, Abivax and 3 Stocks to Watch Heading Into Monday
Stocks in focus: Abivax, Marygold and Neuphoria report losses; Accenture partners with Anthropic, while Lobo Technologies posts H1 growth.
Stocks · News reference
Scancell Earlier Announced All-Share Merger To Acquire Neuphoria, Combined Company To Operate As Scancell, Apply To Trade On Nasdaq Under Symbol SCLT
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Neuphoria Therapeutics Q4 EPS $(0.95) Misses $(0.56) Estimate, Sales $1.174M.
Neuphoria Therapeutics (NASDAQ:NEUP) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.56) by 69.64 percent. This is a 76.13 percent increase over losses of $(3.98) per
The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—NRIM, NEUP, SAFT, and RMAX
Monteverde & Associates PC is investigating four major M&A transactions on behalf of shareholders: Northrim Bancorp's merger with PBCO Financial Corporation, Neuphoria Therapeutics' merger with Scancell Holdings plc, Safety Insurance Group's sale to a Mapfre affiliate, and RE/MAX Holdings' sale to The Real Brokerage Inc. The firm encourages shareholders to contact them regarding potential concerns with these deals.
8-K filing — Neuphoria Therapeutics Inc. (NEUP)
Filed: 2026-07-24 AccNo: 0001213900-26-081052 Size: 18 MB Item 1.01: Entry into a Material Definitive Agreement Item 5.01: Changes in Control of Registrant Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits